Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cav3.1 is a low-voltage activated calcium channel essential for regulating electrical excitability across several organ systems—including brain circuits underlying cognition/memory formation, immune cell signaling, cardiac rhythm generation, vascular tone, and more—making it an attractive target for therapeutic intervention across neurological, cardiovascular, renal, immunological disorders.
T-type channel antagonists could modulate excessive excitability or abnormal rhythmic activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-type voltage-gated calcium channel 3.1 (Cav3.1).